Compounds > amphetamine

amphetamine and quetiapine fumarate

amphetamine has been researched along with quetiapine fumarate in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Goldstein, JM; Litwin, LC; Malick, JB; Sutton, EB1
Malick, JB; Migler, BM; Warawa, EJ1
Jansen, AH; Kruse, CG; McCreary, AC; Olijslagers, JE; Perlstein, B; Wadman, WJ; Werkman, TR1
He, J; Li, XM; Xu, H; Yang, Y; Zhang, X1
Deitemeyer, N; Dobner, PR; Egnatashvili, V; Kinkead, B; Murray, T; Nemeroff, CB1
Dilley, JW; Harrison, G; Loeb, L; Nelson, K1
Hacksell, U; Hubbard, D; McFarland, K1
Beninger, RJ; Martin-Iverson, MT; McLelland, AE1
Arreguin-Campos, R; Caldara, M; Cleij, TJ; Diliën, H; Eersels, K; Heidt, B; Jimenez-Monroy, KL; Lowdon, JW; Rogosic, R; van Grinsven, B1

Other Studies

9 other study(ies) available for amphetamine and quetiapine fumarate

ArticleYear
Seroquel: electrophysiological profile of a potential atypical antipsychotic.
    Psychopharmacology, 1993, Volume: 112, Issue:2-3

    Topics: Action Potentials; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Brain; Clozapine; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Haloperidol; Male; Microelectrodes; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Substantia Nigra

1993
Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug.
    Psychopharmacology, 1993, Volume: 112, Issue:2-3

    Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Basal Ganglia Diseases; Behavior, Animal; Catalepsy; Cats; Cebus; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Fixation, Ocular; Male; Mice; Motor Activity; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Saimiri; Stereotyped Behavior; Swimming

1993
Quetiapine increases the firing rate of rat substantia nigra and ventral tegmental area dopamine neurons in vitro.
    European journal of pharmacology, 2004, Dec-03, Volume: 506, Issue:1

    Topics: Action Potentials; Amphetamine; Animals; Antipsychotic Agents; Dibenzothiazepines; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; In Vitro Techniques; Neurons; Quetiapine Fumarate; Quinpirole; Rats; Rats, Wistar; Substantia Nigra; Time Factors; Ventral Tegmental Area

2004
Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats.
    Behavioural brain research, 2005, May-07, Volume: 160, Issue:1

    Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Anxiety Disorders; Behavior, Animal; Body Temperature; Brain; Cell Count; Dibenzothiazepines; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Immunohistochemistry; Male; Maze Learning; Neurotoxins; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Reaction Time; Time Factors; Tyrosine 3-Monooxygenase

2005
Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:1

    Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Clozapine; Dibenzothiazepines; Female; Haloperidol; Male; Mice; Mice, Inbred C57BL; Neurotensin; Olanzapine; Quetiapine Fumarate; Reflex; Reflex, Startle

2005
Priapism and quetiapine: a case report.
    Psychopharmacology bulletin, 2006, Volume: 39, Issue:1

    Topics: Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Comorbidity; Depressive Disorder; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; HIV Seropositivity; Homosexuality, Male; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Priapism; Psychotic Disorders; Quetiapine Fumarate

2006
Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios.
    Behavioural pharmacology, 2013, Volume: 24, Issue:7

    Topics: Amphetamine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Clozapine; Dopamine; Dose-Response Relationship, Drug; Male; Parkinsonian Disorders; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Urea

2013
The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine.
    Psychopharmacology, 2014, Volume: 231, Issue:22

    Topics: Amphetamine; Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Psychological; Dibenzothiazepines; Drug Synergism; Male; Maze Learning; Quetiapine Fumarate; Rats; Rats, Wistar; Reward

2014
A Molecularly Imprinted Polymer-based Dye Displacement Assay for the Rapid Visual Detection of Amphetamine in Urine.
    Molecules (Basel, Switzerland), 2020, Nov-10, Volume: 25, Issue:22

    Topics: Amphetamine; Amphetamines; Brompheniramine; Bupropion; Coloring Agents; Dose-Response Relationship, Drug; Electrochemical Techniques; False Positive Reactions; Humans; Ibuprofen; Limit of Detection; Molecular Imprinting; Molecularly Imprinted Polymers; Naproxen; Pheniramine; Piperidines; Polymers; Powders; Quetiapine Fumarate; Substance Abuse Detection; Urine

2020